EDMONTON, AB – Aurora Cannabis Inc., in collaboration with German healthcare technology leader, Copeia, launched the English-language version of the Physician Experience Platform (PEP). Developed as a peer-to-peer educational resource for physicians, PEP provides real-world case studies from doctors using medical cannabis as part of patient care.
The English PEP follows the successful rollout of the German version in early 2024. With more than 130 anonymized case studies available, the platform will give healthcare professionals worldwide access to clinical insights into cannabis-based therapies. Each case includes detailed information such as patient history, treated symptoms, therapeutic outcomes, dosage and product data, and documentation of other therapies before and during the cannabis-based medicine treatment. Healthcare providers can also search for local product recommendations based on those used in similar case studies.
The expanded PEP will initially be available to physicians in Canada, United Kingdom, Poland, Malta, the Czech Republic, Australia, and New Zealand.
The PEP platform is gated by DocCheck login access, ensuring that only verified healthcare professionals can view the content. While the English-language platform will initially be read-only, Aurora and Copeia are expected to roll out a future version that would allow physicians worldwide to upload and share case studies, creating a truly international medical cannabis study database and deepening cross-border clinical collaboration.
About Aurora Cannabis Inc.
Aurora serves both the medical and consumer markets across Canada, Europe, Australia, and New Zealand. The Company’s adult-use brand portfolio includes Drift, San Rafael ’71, Daily Special, Tasty’s, Being and Greybeard. Medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co., as well as international brands, Pedanios, IndiMed and CraftPlant. Aurora also has a controlling interest in Bevo Farms Ltd., a North American supplier of propagated agricultural plants.
About Copeia
Founded in 2020, Copeia is a German medical informatics-based technology innovator developing AI- and data-driven solutions to optimize cannabis-based care. Its platform and data-rich ecosystem serve as a single touchpoint for understanding, applying, and reporting on cannabis therapies.
Related Articles:
